Press Releases (08-06-27) Leading vaccine adjuvant provider set to grow in animal vaccine market and to unlock the value of its technology for human vaccines.

Company News (07-09-26) Isconova har utsett Lars Gårdö, tidigare bla VD För investmentbolaget Atle och ordförande i 3i Nordic, till ny ordförande. Styrelsen förstärks samtidigt med flera företrädare för bioteknik- och läkemedelsindustrin.

For information in English, please see Board of Directors

Press Releases (06-12-19) Intervet International BV, has recently launched a new equine influenza and influenza/tetanus vaccine, Equilis Prequenza Te. The vaccine is formulated with Isconova adjuvant technology, produced at Isconova in Uppsala.

Press Releases (06-04-06) Isconova today announced the signing of a distribution agreement with Funakoshi Co, Ltd. Under the terms of the agreement Funakoshi will distribute and promote AbISCO® adjuvants in Japan.